Literature DB >> 12800259

In situ expression and significance of B7 costimulatory molecules within tissues of human gastric carcinoma.

Xiao-Li Chen1, Xu-Dong Cao, An-Jing Kang, Kang-Min Wang, Bao-Shan Su, Yi-Li Wang.   

Abstract

AIM: To explore the role and significance of costimulatory molecules B7H1,B7H2 and ICOS within tissues of human gastric carcinoma and the possible mechanisms in tumor escape.
METHODS: mRNA expressions of costimulatory molecules including B7H1,B7H2,ICOS and B7-1 in tissues of human gastric carcinoma were investigated by in situ hybridization using digoxigenin-labeled oligonucleotide-probes. The tissue of chronic gastric ulcer was used as a control. All data were analyzed by SPSS statistic software.
RESULTS: At the site of gastric carcinoma, mRNA expression levels of B7H1, B7H2 and ICOS were much higher than that of B7-1. Their mRNA positive expression indexes were 0.512+/-0.333, 0.812+/-0.454, 0.702+/-0.359 and 0.293+/-0.253, respectively. The positively stained cells were mainly tumor infiltrating lymphocytes (TILs), and some tumor cells. The difference between them was greatly significant P<0.005. The mRNA expression levels of four molecules were not correlated to the pathological grade and matastasis of gastric carcinoma.
CONCLUSION: ICOS-B7H costimulatory pathway may be predominant at the site of gastric carcinoma. B7-1mRNA might be the basis of ICOS-B7H interaction. ICOS-B7H interaction induces the production of IL-10 which inhibits the antitumor immune responses. Therefore, it is supposed that ICOS-B7H costimulatory pathway may be involved in the negative regulation of cell-mediated immune responses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12800259      PMCID: PMC4611819          DOI: 10.3748/wjg.v9.i6.1370

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  33 in total

1.  ICOS costimulation requires IL-2 and can be prevented by CTLA-4 engagement.

Authors:  J L Riley; P J Blair; J T Musser; R Abe; K Tezuka; T Tsuji; C H June
Journal:  J Immunol       Date:  2001-04-15       Impact factor: 5.422

2.  Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS.

Authors:  S Wang; G Zhu; A I Chapoval; H Dong; K Tamada; J Ni; L Chen
Journal:  Blood       Date:  2000-10-15       Impact factor: 22.113

3.  ICOS is essential for effective T-helper-cell responses.

Authors:  A Tafuri; A Shahinian; F Bladt; S K Yoshinaga; M Jordana; A Wakeham; L M Boucher; D Bouchard; V S Chan; G Duncan; B Odermatt; A Ho; A Itie; T Horan; J S Whoriskey; T Pawson; J M Penninger; P S Ohashi; T W Mak
Journal:  Nature       Date:  2001-01-04       Impact factor: 49.962

4.  ICOS co-stimulatory receptor is essential for T-cell activation and function.

Authors:  C Dong; A E Juedes; U A Temann; S Shresta; J P Allison; N H Ruddle; R A Flavell
Journal:  Nature       Date:  2001-01-04       Impact factor: 49.962

Review 5.  Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity.

Authors:  E C Guinan; J G Gribben; V A Boussiotis; G J Freeman; L M Nadler
Journal:  Blood       Date:  1994-11-15       Impact factor: 22.113

6.  T-cell co-stimulation through B7RP-1 and ICOS.

Authors:  S K Yoshinaga; J S Whoriskey; S D Khare; U Sarmiento; J Guo; T Horan; G Shih; M Zhang; M A Coccia; T Kohno; A Tafuri-Bladt; D Brankow; P Campbell; D Chang; L Chiu; T Dai; G Duncan; G S Elliott; A Hui; S M McCabe; S Scully; A Shahinian; C L Shaklee; G Van; T W Mak; G Senaldi
Journal:  Nature       Date:  1999-12-16       Impact factor: 49.962

7.  Stimulatory effects of B7-related protein-1 on cellular and humoral immune responses in mice.

Authors:  J Guo; M Stolina; J V Bready; S Yin; T Horan; S K Yoshinaga; G Senaldi
Journal:  J Immunol       Date:  2001-05-01       Impact factor: 5.422

8.  Interactions of CD80 and CD86 with CD28 and CTLA4.

Authors:  J H Ellis; M N Burden; D V Vinogradov; C Linge; J S Crowe
Journal:  J Immunol       Date:  1996-04-15       Impact factor: 5.422

9.  Structure and dimerization of a soluble form of B7-1.

Authors:  S Ikemizu; R J Gilbert; J A Fennelly; A V Collins; K Harlos; E Y Jones; D I Stuart; S J Davis
Journal:  Immunity       Date:  2000-01       Impact factor: 31.745

10.  Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells.

Authors:  A J McAdam; T T Chang; A E Lumelsky; E A Greenfield; V A Boussiotis; J S Duke-Cohan; T Chernova; N Malenkovich; C Jabs; V K Kuchroo; V Ling; M Collins; A H Sharpe; G J Freeman
Journal:  J Immunol       Date:  2000-11-01       Impact factor: 5.422

View more
  8 in total

1.  Melanoma cells express ICOS ligand to promote the activation and expansion of T-regulatory cells.

Authors:  Natalia Martin-Orozco; Yufeng Li; Yijun Wang; Shijuan Liu; Patrick Hwu; Yong-Jun Liu; Chen Dong; Laszlo Radvanyi
Journal:  Cancer Res       Date:  2010-11-23       Impact factor: 12.701

Review 2.  Immunotherapy in gastrointestinal cancers.

Authors:  Patrick Grierson; Kian-Huat Lim; Manik Amin
Journal:  J Gastrointest Oncol       Date:  2017-06

3.  A functional variant at miR-132-3p, miR-212-3p, and miR-361-5p binding site in CD80 gene alters susceptibility to gastric cancer in a Chinese Han population.

Authors:  Ruirong Wu; Fuchao Li; Jianjie Zhu; Rong Tang; Qinghua Qi; Xinru Zhou; Rui Li; Weipeng Wang; Dong Hua; Weichang Chen
Journal:  Med Oncol       Date:  2014-07-01       Impact factor: 3.064

4.  CRISPR-Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancer.

Authors:  Shu Su; Zhengyun Zou; Fangjun Chen; Naiqing Ding; Juan Du; Jie Shao; Lin Li; Yao Fu; Bian Hu; Yang Yang; Huizi Sha; Fanyan Meng; Jia Wei; Xingxu Huang; Baorui Liu
Journal:  Oncoimmunology       Date:  2016-11-22       Impact factor: 8.110

5.  ICOSLG-mediated regulatory T-cell expansion and IL-10 production promote progression of glioblastoma.

Authors:  Ryoichi Iwata; Joo Hyoung Lee; Mikio Hayashi; Umberto Dianzani; Kohei Ofune; Masato Maruyama; Souichi Oe; Tomoki Ito; Tetsuo Hashiba; Kunikazu Yoshimura; Masahiro Nonaka; Yosuke Nakano; Lyse Norian; Ichiro Nakano; Akio Asai
Journal:  Neuro Oncol       Date:  2020-03-05       Impact factor: 12.300

6.  B7-H1 enhances proliferation ability of gastric cancer stem-like cells as a receptor.

Authors:  Yupeng Yang; K E Wu; Ende Zhao; Wei Li; Liang Shi; Gengchen Xie; Bin Jiang; Yaxin Wang; Ruidong Li; Peng Zhang; Xiaoming Shuai; Guobin Wang; Kaixiong Tao
Journal:  Oncol Lett       Date:  2015-02-10       Impact factor: 2.967

7.  Helicobacter Pylori Promote B7-H1 Expression by Suppressing miR-152 and miR-200b in Gastric Cancer Cells.

Authors:  Gengchen Xie; Wei Li; Ruidong Li; Ke Wu; Ende Zhao; Yu Zhang; Peng Zhang; Liang Shi; Di Wang; Yuping Yin; Rui Deng; Kaixiong Tao
Journal:  PLoS One       Date:  2017-01-05       Impact factor: 3.240

8.  Implication of ARID1A Undercurrents and PDL1, TP53 Overexpression in Advanced Gastric Cancer.

Authors:  Jasiya Qadir; Sabhiya Majid; Mosin Saleem Khan; Fouzia Rashid; Mumtaz Din Wani; Showkat Ahmad Bhat
Journal:  Pathol Oncol Res       Date:  2021-12-03       Impact factor: 3.201

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.